Dr. Thomas Herzog Named Director of Gynecologic Oncology at NewYork-Presbyterian Hospital/Columbia University Medical Center

Joins Two New Appointments in Obstetrics and Gynecology: Dr. Carmel J. Cohen and Dr. Bhavana Pothuri

Dec 1, 2004


A specialist in the state-of-the-art diagnosis and treatment of gynecologic cancer, Dr. Thomas Herzog has been named Director of the Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology at NewYork-Presbyterian Hospital/Columbia University Medical Center. He has also been appointed Professor of Obstetrics and Gynecology at Columbia University College of Physician and Surgeons. Dr. Herzog joined NewYork-Presbyterian/Columbia from Washington University School of Medicine in St. Louis, where he conducted extensive research in the underlying causes and mechanisms of gynecologic cancer.

"As one of the country's leading gynecologic oncologists, Dr. Herzog is an outstanding addition to Columbia's renowned gynecologic oncology staff," says Dr. Mary E. D'Alton, obstetrician-in-chief at NewYork-Presbyterian/Columbia and Chair of the Department of Obstetrics and Gynecology and the Willard C. Rappleye Professor of Obstetrics and Gynecology at Columbia University College of Physicians and Surgeons.

Dr. Herzog has a keen interest in applying the principles learned from the lab to the clinical setting. He is a principal investigator in a number of Gynecologic Oncology Group (GOG) clinical trials focusing on ovarian cancer. He has authored or co-authored more than 100 peer-reviewed articles and has lectured extensively.

Dr. Herzog graduated from medical school at the University of Cincinnati, and completed his residency at Cincinnati's Good Samaritan Hospital in 1990. At the Washington University School of Medicine in St. Louis, he completed a fellowship in gynecologic oncology in 1993. There, he most recently served as an associate professor and the Director of the Gynecologic Oncology fellowship training program. He is board certified in both obstetrics and gynecology and gynecologic oncology.

Other recent appointments to the NewYork-Presbyterian/Columbia Department of Obstetrics and Gynecology include Dr. Carmel J. Cohen, who also joins the division of gynecologic oncology, and Dr. Bhavana Pothuri, who will direct the NewYork-Presbyterian/Columbia tumor clinic. Dr. Cohen was the founder and longstanding chairman of Gynecologic Oncology and Vice Chair of the Department of Obstetrics and Gynecology at Mt. Sinai. He is known as a leader in the field through his research and clinical accomplishments.

NewYork-Presbyterian Hospital

New York-Presbyterian Hospital is the largest not-for-profit, non-sectarian hospital in the country. It provides state-of-the art inpatient, ambulatory and preventive care in all areas of medicine at five major centers: New York-Presbyterian hospital/Columbia University Medical Center, New York-Presbyterian Hospital/Weill Cornell Medical Center, Children's Hospital of New York-Presbyterian, the Allen Pavilion, and the Westchester Division. It consistently ranks as one of the top hospitals in the country in U.S.News & World Report's guide to "America's Best Hospitals." The New York-Presbyterian Healthcare System – an affiliation of acute-care and community hospitals, long-term care facilities, ambulatory – serves one in four patients in the New York metropolitan area.

Columbia University Medical Center

Located in New York City, Columbia University Medical Center provides international leadership in basic and clinical research, medical education, and health care. The medical center includes the dedicated work of many physicians, scientists, and other health professionals at the College of Physicians & Surgeons, the School of Dental & Oral Surgery, the School of Nursing, the Mailman School of Public Health, the biomedical departments of the Graduate School of Arts and Sciences, and allied research centers and institutions. The pioneering tradition of Columbia University health scientists, who achieved some of the 20th century's most significant medical breakthroughs, continues today.